Cargando…
The New Proactive Approach and Precision Medicine in Crohn’s Disease
The proactive approach to Crohn’s disease (CD) management advocates moving toward algorithmic tight-control scenarios that are designed for each CD phenotype to guide remission induction, maintenance therapy, active monitoring, and multidisciplinary care to manage the complexities of each inflammato...
Autores principales: | Zittan, Eran, Gralnek, Ian M., Berns, Marc S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7400127/ https://www.ncbi.nlm.nih.gov/pubmed/32635316 http://dx.doi.org/10.3390/biomedicines8070193 |
Ejemplares similares
-
Fecal calprotectin correlates with active colonic inflammatory bowel disease but not with small intestinal Crohn's disease activity
por: Zittan, Eran, et al.
Publicado: (2018) -
Preoperative Exclusive Total Parental Nutrition is Associated with Clinical and Laboratory Remission in Severe Active Crohn’s Disease—A Pilot Study
por: Zittan, Eran, et al.
Publicado: (2020) -
Post-Induction High Adalimumab Drug Levels Predict Biological Remission at Week 24 in Patients With Crohn's Disease
por: Zittan, Eran, et al.
Publicado: (2021) -
Harnessing the Power of Precision Medicine and Novel Biomarkers to Treat Crohn’s Disease
por: Kriger-Sharabi, Ofra Aviva, et al.
Publicado: (2023) -
Proactive measurement of infliximab drug levels in children with Crohn’s disease
por: Holland, Kathleen, et al.
Publicado: (2022)